For customers outside of Japan
EPS has operated in China since 2006 and we have set up offices across the region. With approximately 10 years of combined clinical research experience, EPS believes that it can provide possible solutions to bring your project to success.
Health Expenditure per Capita
Source: Financing Global Health Database 2018
Source: The World Bank
Burden of Disease DALYs Causes % of Total DALYs
(2017, all ages/both sexes)
Ischemic heart disease (8.13%)
Chronic obstractive pulmonary
Source: Institute Health Matrics and Evaluation GBD
NDA Approval Time
Study Start-up Time
Clinical Trials in China: the potential and pitfalls
Clinical trials are a global industry, but many companies are reconsidering where they will conduct their work in the future. One of the most promising locations is China. The potential for clinical trials in China is great ...
Post-marketing surveillance in China: what it reveals
With a population of over 1.3 billion people and an annual increase of approximately 16 million people, China requires 500 million vaccine doses each year. Recent additions to the national immunization schedule combined ...
Share this page